- Home
- CBT
as 04-29-2025 4:00pm EST
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
Upcoming Earnings Alert:
Get ready for potential market movements as Cabot Corporation CBT prepares to release earnings report on 05 May 2025.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 4.4B | IPO Year: | N/A |
| Target Price: | $92.67 | AVG Volume (30 days): | 439.2K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.51 | EPS Growth: | -2.37 |
| 52 Week Low/High: | $73.63 - $117.46 | Next Earning Date: | 05-05-2025 |
| Revenue: | $3,991,000,000 | Revenue Growth: | 1.71% |
| Revenue Growth (this year): | 3.2% | Revenue Growth (next year): | 3.44% |
Latest Cabot Corporation News
CBT Breaking Stock News: Dive into CBT Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Cabot (CBT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Investing.com
5 days ago
JP Morgan downgrades Orion amid economic uncertainty
Argus Research
7 days ago
CBT: Raising target price to $83.00
Argus Research
14 days ago
CBT: Raising target price to $82.00
Zacks
20 days ago
Albemarle (ALB) Stock Jumps 19.1%: Will It Continue to Soar?
Argus Research
21 days ago
CBT: Lowering target price to $79.00
GlobeNewswire
a month ago
Cabot Corporation to Announce Second Quarter 2025 Operating Results
Argus Research
a month ago
CBT: What does Argus have to say about CBT?
Compare CBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CBT Cabot Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.